Get a free sample of Attention Deficit Hyperactivity Disorder Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Attention Deficit Hyperactivity Disorder Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Attention Deficit Hyperactivity Disorder Market Size
The global attention deficit hyperactivity disorder market size was valued at USD 15.8 billion in 2023 and is estimated to grow at a CAGR of over 5.1% from 2024 to 2032. The growth of the industry is being driven by several critical factors, including the rising global prevalence of ADHD, advances in diagnostic technologies, and the development of innovative treatment options.
For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 7 million children in the U.S. aged 3 to 17 years (11.4%) have been diagnosed with ADHD, based on data from a 2022 national parent survey.
Moreover, the increase in awareness and understanding of the disorder drives the demand for improved diagnosis and treatment solutions that contribute to the market progression. Additionally, treatment options for ADHD are expanding with the introduction of both pharmacological and non-pharmacological interventions.
ADHD is a neurodevelopmental disorder that affects both children and adults, with symptoms such as inattentiveness, hyperactivity, and impulsiveness. The market encompasses the diagnosis, treatment, and management of ADHD. It includes pharmaceutical therapies, behavioral interventions, diagnostic tools, and support services aimed at improving patient outcomes in both pediatric and adult populations.
Who are some of the prominent players in the attention deficit hyperactivity disorder industry?
Key players in the industry include Aytu BioPharma, Eli Lilly and Company, Ironshore, Janssen Pharmaceuticals, Lupin, Mallinckrodt, Novartis, and Pfizer.
What is the size of the U.S. attention deficit hyperactivity disorder market?
U.S. ADHD market is expected to grow at a 5.1% CAGR, reaching USD 10.2 billion by 2032, supported by high awareness and diagnosis rates, along with a strong focus on both medication and behavioral therapy sectors.
How big is the attention deficit hyperactivity disorder market?
The global attention deficit hyperactivity disorder industry was valued at USD 15.8 billion in 2023 and is estimated to grow at a 5.1% CAGR from 2024 to 2032, driven by the rising global prevalence of ADHD and advancements in diagnostic technologies.
Why is the use of stimulants rising in the ADHD market?
The stimulants segment dominated the market with USD 11.2 billion in 2023, as these medications are highly effective, with approximately 70-80% of patients responding positively.